IIP Testing and Recognition Initiative
The Centers for Disease Control and Prevention (CDC), American Immunization Registry Association (AIRA), Drummond Group and HIMSS lead and coordinate the IIP Testing and Recognition initiative which gives EHR developers the opportunity to adopt, demonstrate and raise awareness of their software product’s inclusion of high-priority immunization capabilities. This was developed through a consensus process involving experts and leaders representing IIS, EHRs and other health IT, HIEs, clinicians, public health and other critical partners. Undergoing IIP Testing and Recognition is offered at no-cost to health IT market suppliers and testing is powered by the National Institute of Standards and Technology (NIST) in collaboration with Drummond Group as the authorized testing body.
The IIP Testing and Recognition initiative has been approved by the Office of the National Coordinator for Health Information Technology (ONC) as an alternative testing method for (f)(1) Transmission to immunization registries certification criteria within the ONC Health IT Certification Program. ONC acts as a strategic advisor to IIP testing.
A pipeline approach has been developed to identify opportunities for strategic application of the IIP Collaborative’s recommended solutions to testing within the Testing and Recognition initiative. Updates to the Test Plan are made regularly and include efforts resulting from work by the IIP Collaborative.
Over time, the test plan will be updated with the goal to continue to improve immunization interoperability and information sharing with IIS. New testing functionality will be introduced as immunization data exchange evolves and existing requirements may be deprecated to ensure that the test plan remains current, relevant and impactful.
Product Testing Eligibility
Criteria have been developed to define appropriate candidates for IIP testing including:
- Vendor product must be an electronic health record (EHR), as defined by HIMSS as: “an electronic record of health-related information on an individual that conforms to nationally recognized interoperability standards and that can be created, managed, and consulted by authorized clinicians and staff across more than one health care organization”
- Health IT market suppliers must clearly declare the product and version/release to be tested and recognized and provide the anticipated deployment schedule
- Health IT market suppliers must clearly declare if other products are being used to meet any of the capabilities tested through the process
- Health IT market suppliers must be willing to participate in evaluation activities and re-testing as appropriate
- A product does not need to be fully implemented in a production environment, but priority will be given to products and versions currently implemented in clinical locations providing immunizations
Join Our Leaders
Join other industry leaders and become an IIP recognized vendor!
- PCC EHR – V9.5.4 Build 22340/Clinical Version V9.5.4 Build 22340
- PCC EHR – V9.7.1 Build 23046/Clinical Version V9.7.1 Build 23054
Passed IIP Test Plan v10.0 (2022) with notable exception.
Product tested: Office Practicum OP Version 20
Passed with notable exception: IIP Test Plan 7.6 (August 2019)
Product tested: The Physicians – Practitioners Office Assistant Immunization Capabilities Version 3.1
Passed with notable exception: IIP Test Plan 5.6 (February 2018)
Products tested: Cerner FirstNet (Immunizations) Version 2 and PowerChart Immunizations Version 10
Passed with notable exception: IIP Test Plan 5.6 (December 2017)
Product tested: Qvera Interface Engine Version 3.0.44 Build 8640
Passed without exception: IIP Test Plan 5.6 (October 2017)
IIP test plan materials and guidance include:
- IIP Capabilities will help your customers deliver better care to their patients
- IIP Test Plan break down test cases and related IIP testing capabilities
- The IIP Test Plan Overview describes test steps and the associated required, trial and discovery capabilities
- EHR developers have the flexibility of selecting which capabilities to test to (90% are required), in addition to the required ONC (f)(1) requirements
Supporting materials and resources for user-centered design include:
- User-Centered Design Primer offers guidance on how to conduct a user-centered design (UCD) process to improve usability outcomes related to the use of immunization program functionality in EHRs and other clinical software
- User-Centered Model Documentation includes immunization-related content and user interface designs from business workflow requirements to enable the creation of functional prototypes using the UCD model documentation. It also includes discussion on the use of the UCD model to explore immunization-related forecasting and data quality
- User-Centered Design Process a description of the use of the UCD model to explore immunization-related reconciliation and inventory management